{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:10:15Z","timestamp":1777929015762,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Attendance as well as re-attendance is important for an effective screening program for breast cancer. We aimed to evaluate re-attendance among women with a false positive versus negative screening result in BreastScreen Norway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study sample included 3,990,388 screening examinations performed between 1996 and 2021 among women with an invitation to the subsequent screening examination available, that is, women eligible for re-attendance in the period 1998\u20132023. Mixed logistic regression was used to analyze the association between screening results, including negative versus any false positive, and negative versus false positive with or without a needle biopsy, and attendance in the subsequent screening round. We adjusted for screening history and age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Crude attendance rates in the subsequent screening round were 90.8% for those with a negative result and 88.3% for those with a false positive result. The adjusted odds ratio (OR) for re-attendance after a false positive result was 0.91 (95% CI: 0.87\u20130.93) using a negative screening result as the reference. Also using negative screening result as the reference, adjusted OR for re-attendance among those with a false positive screening result without a needle biopsy was 0.93 (95% CI: 0.91\u20130.96) while it was 0.85 (95% CI: 0.82\u20130.87) for those with a false positive result including a biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women invited to BreastScreen Norway re-attended screening less often after a false positive compared to a negative result. The benefits of regular attendance should be communicated to women targeted for breast cancer screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09691413251329671","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:51:26Z","timestamp":1744267886000},"page":"224-230","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Re-attendance to mammographic screening after a false positive screening result"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5437-0363","authenticated-orcid":false,"given":"Marthe","family":"Larsen","sequence":"first","affiliation":[{"name":", Norwegian Institute of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1477-1968","authenticated-orcid":false,"given":"Nataliia","family":"Moshina","sequence":"additional","affiliation":[{"name":", Norwegian Institute of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sne S\u00f8rlien","family":"Holen","sequence":"additional","affiliation":[{"name":", Norwegian Institute of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Burns","family":"Bergan","sequence":"additional","affiliation":[{"name":", Norwegian Institute of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-8939","authenticated-orcid":false,"given":"Solveig","family":"Hofvind","sequence":"additional","affiliation":[{"name":", Norwegian Institute of Public Health"},{"name":"Department of Health and Care Sciences, Faculty of Health Sciences, UiT The Arctic University of Norway, Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_2_3_2","unstructured":"European guidelines on breast cancer screening and diagnosis. https:\/\/cancer-screening-and-care.jrc.ec.europa.eu\/en\/ecibc\/european-breast-cancer-guidelines (2017 accessed 28 August 2024)."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1504363"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203935"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/09691413231199583"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2023.102516"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046660"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jms.8.2.99"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002943"},{"key":"e_1_3_2_11_2","article-title":"Mobile phone messaging reminders for attendance at healthcare appointments","volume":"2013","author":"Gurol-Urganci I","year":"2013","unstructured":"Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, et al. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev 2013; 2013: Cd007458.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.0603"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11622"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11360-0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/M24-0123"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1581-4"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta17130"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841860801935483"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-7-200704030-00006"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.573"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0358-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4519"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32330"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0524-4"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1466"},{"key":"e_1_3_2_26_2","unstructured":"Bj\u00f8rnson E Holen \u00c5S Sagstad S et al. BreastScreen Norway: 25 years of organized screening. Report no. ISBN 978-82-93804-03-1 2022. Cancer Registry of Norway."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023918610664"},{"key":"e_1_3_2_28_2","unstructured":"Helse- og omsorgsdepartementet. Forskrift om innsamling og behandling av helseopplysninger i Kreftregisteret (Kreftregisterforskriften) https:\/\/lovdata.no\/dokument\/SF\/forskrift\/2001-12-21-1477 (2001 accessed 28 August 2024)."},{"key":"e_1_3_2_29_2","unstructured":"Hofvind S Tsuruda K Mangerud G et al. The Norwegian Breast Cancer Screening Program 1996-2016: Celebrating 20 years of organised mammographic screening. In: Cancer in Norway 2016 - Cancer incidence mortality survival and prevalence in Norway 2017."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34530"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1258\/jms.2012.012083"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34078"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103702"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/09691413241280791"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31840"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.09.001"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.981"}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413251329671","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413251329671","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413251329671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:26:17Z","timestamp":1777677977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413251329671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1177\/09691413251329671"],"URL":"https:\/\/doi.org\/10.1177\/09691413251329671","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}